The use of carbon-coated spheres, calcium hydroxylapatite, polyacrylamide hydrogel, or polydimethylsiloxane may be considered medically necessary to treat stress urinary incontinence in men and women who have failed appropriate conservative therapy.
The use of autologous cellular therapy (eg, myoblasts, fibroblasts, muscle-derived stem cells, adipose-derived stem cells), autologous fat, and autologous ear chondrocytes to treat stress urinary incontinence is considered investigational.
The use of any other periurethral bulking agent, including, but not limited to Teflon, to treat stress urinary incontinence is considered investigational.
The use of periurethral bulking agents to treat urge urinary incontinence is considered investigational.
The use of perianal bulking agents to treat fecal incontinence is considered investigational.